Navigation Links
Metabolic Solutions Development Company to Present Recent Findings on the Therapeutic Potential of Increasing Brown Fat in the Treatment of Diabetes at Annual American Diabetes Association Conference
Date:6/21/2011

l for this mechanism of action to produce positive effects directly on human insulin-secreting pancreatic beta-cells.
  • June 27 at 1 p.m. PT, "Insulin Resistance in ob/ob Mice Is Ameliorated by Thiazolidinediones That Do Not Activate PPARg."  This presentation from the laboratory of Dr. Brian Finck at Washington University in St. Louis provides a detailed comparison of the clinical candidate in mouse models of diabetes with insight into the mechanism of action.

MSDC has two novel insulin sensitizers in clinical trials for the treatment of type 2 diabetes. Phase 2a clinical data from the company's lead candidate, MSDC-0160, demonstrated that it improved insulin sensitivity and lowered blood glucose levels in humans without the side effects of the current market leading diabetes medicines. The compound also demonstrated significant improvements in other important metabolic disease parameters, including blood pressure and lipids. A phase 2b study of MSDC-0160 is currently under way in patients with type 2 diabetes and data are expected to be available in January 2012.

A Phase 2a trial of MSDC-0602, the company's second drug candidate for the treatment of type 2 diabetes is currently under way.  Results of this study are expected to be available in September 2011.  A Phase 2b study of MSDC-0602 is targeted to begin in the first quarter of 2012.

About Metabolic Solutions Development Company:

Metabolic Solutions Development Company (www.msdrx.com) is a drug discovery and development company exploiting novel molecular targets to develop new therapies for metabolic diseases associated with altered mitochondrial function, especially insulin resistance and type 2 diabetes. The company has raised nearly $50 million in support of the development of its pioneer and lead products, MSDC-0160 (currently in
'/>"/>

SOURCE Metabolic Solutions Development Company
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. GT Life Sciences Broadens Intellectual Property Portfolio with Issuance of U.S. Patent on Core Computational Systems and Methods for Genomic-based Metabolic Modeling
2. Creating a Road Map for Successful Metabolic New Product Launches
3. Cytotech Labs Unravels Hallmark Insight Into Metabolic Control of Cancer, Presents Work at Major AACR Cancer Meeting
4. Metabolic Solutions Development Company Launches Phase 2a Trial of Its Second Compound to Treat Type 2 Diabetes
5. Dave Anderson and William Thomsen Join SRI Internationals Center for Advanced Drug Research to Lead Programs in Proteomics and Metabolic Disease Drug Discovery
6. Bionovo Announces Publication Describing How Metabolic Adaptability Contributes to the Metastasis of Tumors
7. Metabolic Status Before Pregnancy Predicts Subsequent Gestational Diabetes
8. Metabolic Solutions Development Company to Present Research Findings to European Association for the Study of Diabetes
9. Windhover Information Names D-Tagatose One of Top 10 Most Promising CV/Metabolic Drugs in Development
10. Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity From Its Broad Metabolic Disease Franchise at ADA Scientific Sessions
11. Reportlinker Adds Stakeholder Opinions: Cardiovascular and Metabolic Generics - Generics continue to gain prominence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... 2013 Faruqi & Faruqi, LLP, a ... securities fraud at AVEO Pharmaceuticals, Inc. ("AVEO" or ... http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) The investigation focuses ... federal securities laws by issuing materially false and/or ... trials for Tivopath (tivozanib) (titled "TIVO-1").  Specifically, the ...
(Date:5/17/2013)... , May 17, 2013  Sorrento Therapeutics, Inc. ... Fast-Track Advanced Technology Small Business Technology Transfer Research ... Allergy and Infectious Diseases (NIAID), a division of ... development of novel human antibody therapeutics to combat ... or Staph) infections, including methicillin-resistant S. aureus ...
(Date:5/17/2013)... 2013  Sony Biotechnology Inc. ("Sony") today announced the launch ... 130um sorting chip.  Sony will also be exhibiting its newly ... Cell Sorter, the EC800 flow cytometer, and new SP6800 Spectral ... which will be held at the San Diego ... , from May 20 - 22.  ...
Breaking Medicine Technology:Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Sony Delivers New Technology for Science to CYTO 2013 2
... & LUND, Sweden--(BUSINESS WIRE)--May 1, 2007 - ... today,announced that data from a 36-week, randomized, ... oral 0.6 mg,dose of laquinimod given daily ... by 38 percent in RRMS,patients and was ...
... pivotal phase III study in women with recurrent ... 2007,/PRNewswire-FirstCall/ -- A new study further supports the ... being,studied for the treatment of ovarian cancer. The ... protein, which triggers,a series of events that selectively ...
Cached Medicine Technology:Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 2Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 3Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 4Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 5Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 6New Research Results Show That Investigational Drug Phenoxodiol,Targets Cancer Protein, Causing Cancer Cell Death 2New Research Results Show That Investigational Drug Phenoxodiol,Targets Cancer Protein, Causing Cancer Cell Death 3New Research Results Show That Investigational Drug Phenoxodiol,Targets Cancer Protein, Causing Cancer Cell Death 4New Research Results Show That Investigational Drug Phenoxodiol,Targets Cancer Protein, Causing Cancer Cell Death 5
(Date:5/18/2013)... (PRWEB) May 18, 2013 John Ravera, D.D.S., ... the addition of a new member to his dental team, ... worked in the field for over 10 years. She received ... honors, and was elected a member of Sigma Pi Alpha, ... profession. Marino enjoys working with patients of all ages, helping ...
(Date:5/18/2013)... CA (PRWEB) May 18, 2013 ... latest update to consumers about transvaginal mesh ... federal court Resource4thePeople reports that plaintiffs have ... to court documents. , The rulings came ... District Court in the Southern District of ...
(Date:5/18/2013)... 2013 Creation's Gold has released its ... which features unmatched potency and purity that serves to ... up to provide the very best quality products to ... their wellness goals. The goal is to provide people ... lives. We started by supplying only the best premium ...
(Date:5/17/2013)... NEW YORK, May 18, 2013. Chronic trauma can inflict ... anxiety. Previous imaging studies of people with post-traumatic stress ... can over-or under-react in response to stressful tasks, such ... photo of a threatening face. Now, researchers at NYU ... what happens in the brains of combat veterans with ...
(Date:5/17/2013)... Daily Gossip announced on Monday that their reporters ... Program Yourself Thin regime, Jim Katsoulis. , ... the end of the month in order to teach readers ... and lead a healthy lifestyle, free of food cravings and ... is available for only $97 and it comes with six ...
Breaking Medicine News(10 mins):Health News:Newport Beach Cosmetic Dentist John Ravera Adds New Member to Dental Team 2Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 2Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 3Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 4Health News:Creation's Gold Launches Potent Garcinia Cambogia Supplement for Weight Loss 2Health News:For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests 2Health News:Program Yourself Thin Review and Secrets Revealed By Daily Gossip Magazine 2
... KENILWORTH, N.J., Sept. 1 Schering-Plough Corporation (NYSE: ... 12-hour allergy medicine found in the allergy aisle. New CLARITIN 12-Hour ... indoor and outdoor allergy symptoms. The product is available for ... (Photo: http://www.newscom.com/cgi-bin/prnh/20090901/NY68186 ) , ...
... , , , ... workers in today,s economy add additional stress to already overworked employees, ... National Safety Council estimates that employers pay almost $1 billion per ... indirect costs related to workers, compensation. , , ...
... September 2009: The REVISE Study (Reveal in the Investigation of ... in the United Kingdom, previously thought to be suffering from ... fact had symptoms as a result of an abnormal pattern ... REVISE is the first study to show that, ...
... VidaGas propane energy company secures $1.4M investment from ... Sept. 1 VillageReach, the Seattle-based social enterprise that increases ... Foundation for Community Development (FDC), a Mozambique non profit that ... Oasis Fund, a European commercial investment fund specializing in social ...
... ... a Complete Electronic System to ,Improve Patient Care , ... Atlanta, GA (Vocus) September 1, 2009 -- Thousands ... health records. While this has made improvements in patient care, an electronic health records ...
... BUENOS AIRES, Argentina, Sept. 1 Frost & ... 2009 Customer Value Leadership Award in the Latin American computed ... continuously add value to new and existing healthcare providers, positioning ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) , ...
Cached Medicine News:Health News:New Non-Drowsy CLARITIN(R) 12-Hour Gets Allergy Sufferers Through Their Busy Day 2Health News:New Non-Drowsy CLARITIN(R) 12-Hour Gets Allergy Sufferers Through Their Busy Day 3Health News:Workers' Compensation Networks Evolve to Meet Changing Needs of Today's Market 2Health News:Workers' Compensation Networks Evolve to Meet Changing Needs of Today's Market 3Health News:Syncope and implantable loop recorders: Good value for money? 2Health News:Syncope and implantable loop recorders: Good value for money? 3Health News:VillageReach, Foundation for Community Development and Oasis Fund Announce Strategic Investment in Mozambique Social Business 2Health News:VillageReach, Foundation for Community Development and Oasis Fund Announce Strategic Investment in Mozambique Social Business 3Health News:VillageReach, Foundation for Community Development and Oasis Fund Announce Strategic Investment in Mozambique Social Business 4Health News:Electronic Information Exchange Is Critical to Closing the Gap in Health Care Reform 2Health News:Electronic Information Exchange Is Critical to Closing the Gap in Health Care Reform 3Health News:Electronic Information Exchange Is Critical to Closing the Gap in Health Care Reform 4Health News:Frost & Sullivan Recognizes Carestream Health with the 2009 Latin American Computed Radiology Customer Value Leadership Award 2Health News:Frost & Sullivan Recognizes Carestream Health with the 2009 Latin American Computed Radiology Customer Value Leadership Award 3Health News:Frost & Sullivan Recognizes Carestream Health with the 2009 Latin American Computed Radiology Customer Value Leadership Award 4
... Surgical Markers allows the surgeon ... with a scrub-resistant, gentian violet ... are provided sterile, with a ... in peel pouches. Micro tip ...
... violet ink stands up ... scale ruler printed on ... quick measuring. Flexible, smudge-proof ... inch and metric scales. ...
Broad tip, gentian violet, sterile, disposable...
Double-ended, one end sharp, other end blunt, 7 1/2", double-ended, 5 mm wide....
Medicine Products: